Anti-NGAL/ LCN2/ 24p3 functional antibody

Anti-NGAL/ LCN2/ 24p3 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LCN2/LCN2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T72010-Ab-1/ GM-Tg-hg-T72010-Ab-2Anti-Human LCN2 monoclonal antibodyHuman
GM-Tg-rg-T72010-Ab-1/ GM-Tg-rg-T72010-Ab-2Anti-Rat LCN2 monoclonal antibodyRat
GM-Tg-mg-T72010-Ab-1/ GM-Tg-mg-T72010-Ab-2Anti-Mouse LCN2 monoclonal antibodyMouse
GM-Tg-cynog-T72010-Ab-1/ GM-Tg-cynog-T72010-Ab-2Anti-Cynomolgus/ Rhesus macaque LCN2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T72010-Ab-1/ GM-Tg-felg-T72010-Ab-2Anti-Feline LCN2 monoclonal antibodyFeline
GM-Tg-cang-T72010-Ab-1/ GM-Tg-cang-T72010-Ab-2Anti-Canine LCN2 monoclonal antibodyCanine
GM-Tg-bovg-T72010-Ab-1/ GM-Tg-bovg-T72010-Ab-2Anti-Bovine LCN2 monoclonal antibodyBovine
GM-Tg-equg-T72010-Ab-1/ GM-Tg-equg-T72010-Ab-2Anti-Equine LCN2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T72010-Ab-1/ GM-Tg-hg-T72010-Ab-2; GM-Tg-rg-T72010-Ab-1/ GM-Tg-rg-T72010-Ab-2;
GM-Tg-mg-T72010-Ab-1/ GM-Tg-mg-T72010-Ab-2; GM-Tg-cynog-T72010-Ab-1/ GM-Tg-cynog-T72010-Ab-2;
GM-Tg-felg-T72010-Ab-1/ GM-Tg-felg-T72010-Ab-2; GM-Tg-cang-T72010-Ab-1/ GM-Tg-cang-T72010-Ab-2;
GM-Tg-bovg-T72010-Ab-1/ GM-Tg-bovg-T72010-Ab-2; GM-Tg-equg-T72010-Ab-1/ GM-Tg-equg-T72010-Ab-2
Products NameAnti-LCN2 monoclonal antibody
Formatmab
Target NameLCN2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Diagnostic target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LCN2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T72010-Ag-1Recombinant multi-species NGAL/ LCN2/ 24p3 protein
    ORF Viral VectorvGMLP002859human LCN2 Lentivirus particle
    ORF Viral VectorpGMLP002859human LCN2 Lentivirus plasmid
    ORF Viral VectorpGMAAV000092rat Lcn2 AAV plasmid
    ORF Viral VectorpGMLPm001038mouse Lcn2 Lentivirus plasmid
    ORF Viral VectorvGMAAV000092rat Lcn2 AAV particle
    ORF Viral VectorvGMLPm001038mouse Lcn2 Lentivirus particle


    Target information

    Target IDGM-T72010
    Target NameLCN2
    Gene ID3934,16819,170496,697208,526639,100070310
    Gene Symbol and Synonyms24p3,LCN2,MSFI,NGAL,NRL,p25,Sip24
    Uniprot AccessionP80188,P30152
    Uniprot Entry NameNGAL_HUMAN,NGAL_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, Diagnostics Biomarker
    DiseaseProstate Cancer, Complications of kidney transplant, Congenital hydronephrosis, Congenital occlusion of ureteropelvic junction, Contact with and (suspected) exposure to hazardous aromatic compounds, Contrast - Induced Nephropathy, Delayed Graft Function, Dent disease, Diabetic Nephropathy, HIV-Associated Nephropathy, Hydronephrosis, Hypertension, Impaired renal function disease, Injury to Kidney, Intraoperative Renal Injury, Kidney transplant rejection, Lupus Glomerulonephritis, Neonatal urinary tract infection, Nephrectomy, Nephropathy induced by other drugs, medicaments and biological substances, Nephrotic syndrome, Nephrotic syndrome with diffuse membranous glomerulonephritis, Proteinuria, Renal fibrosis, Renovascular hypertension, Sepsis due to Enterococcus, Systemic inflammatory response syndrome (SIRS) of non-infectious origin with acute organ dysfunction, Systemic lupus erythematosus (SLE), Transplanted Heart Complication, Type 1 diabetes mellitus with diabetic nephropathy, Acute pancreatitis, Asphyxia neonatorum, Autosomal Dominant Polycystic Kidney Disease, Cardiogenic shock, Chronic Kidney Disease, Type 2 diabetes mellitus, Vasculitis, Vesicoureteral reflux
    Gene EnsemblENSG00000148346
    Target ClassificationN/A

    The target: LCN2, gene name: LCN2, also named as 24p3, MSFI, NGAL, p25. This gene encodes a protein that belongs to the lipocalin family. Members of this family transport small hydrophobic molecules such as lipids, steroid hormones and retinoids. The protein encoded by this gene is a neutrophil gelatinase-associated lipocalin and plays a role in innate immunity by limiting bacterial growth as a result of sequestering iron-containing siderophores. The presence of this protein in blood and urine is an early biomarker of acute kidney injury. This protein is thought to be be involved in multiple cellular processes, including maintenance of skin homeostasis, and suppression of invasiveness and metastasis. Mice lacking this gene are more susceptible to bacterial infection than wild type mice. [provided by RefSeq, Sep 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.